首页 | 本学科首页   官方微博 | 高级检索  
     

中晚期食管癌98例同步放化疗的疗效观察
引用本文:施哈日巴拉,侯斯琴高娃,王大鹏,施晓辉. 中晚期食管癌98例同步放化疗的疗效观察[J]. 实用癌症杂志, 2011, 26(5): 475-476,485
作者姓名:施哈日巴拉  侯斯琴高娃  王大鹏  施晓辉
作者单位:1. 内蒙古民族大学附属医院肿瘤科,028000
2. 内蒙古自治区医院外科,010000
摘    要:目的探讨同期放化疗对中晚期食管癌的疗效。方法 98例食管癌中43例行单纯放射治疗(单放组),以6 MVX常规照射,2 Gy/次,5次/周,照射总剂量为50 Gy,另55例行化放疗联合治疗(化放组),予顺铂(DDP)联合氟尿嘧啶(5-Fu)(DDP 20 mg/m2,d1~d5;5-Fu 500 mg/m2,d1~d5),28天为1个周期,放疗方案同单放组,观察两组的近期疗效、远期疗效和不良反应。结果化放组有效率(RR)为65.4%,高于单放组(44.1%)(P〈0.05)。KPS评分化放组较单放组显著提高(P〈0.05),化放组3年生存率为11.9%,高于单放组(6.9%)(P〈0.05)。两组主要不良反应包括白细胞减少、消化道反应和放射性食管炎,化放组白细胞减少发生率高于单放组(P〈0.05)。结论对中晚期食管癌患者,同期放化疗较单纯放疗的近期疗效更好,可明显改善患者的生存质量,延长患者生存时间,且相对安全。

关 键 词:食管癌  同步放化疗  单纯放疗  生存率

Clinical Research of Chemoradiotherapy for 98 Cases Advanced Esophasead Cancer
SHI HA RI-Ba la,HOU SI-Qing gao wa,WANG Da-peng,et al.. Clinical Research of Chemoradiotherapy for 98 Cases Advanced Esophasead Cancer[J]. The Practical Journal of Cancer, 2011, 26(5): 475-476,485
Authors:SHI HA RI-Ba la  HOU SI-Qing gao wa  WANG Da-peng  et al.
Affiliation:SHI HA RI-Ba la,HOU SI-Qing gao wa,WANG Da-peng,et al.Deartment of Oncology,Affilicated Hospital of Inner Mongolia University for the Nationalities,Tongliao,028000
Abstract:Objective To evaluate the effects of chemoradiotherapy for esophaseal cancer.Methods Of the 98 patients with advanced esophageal cancer,43 patients were treated by conformal radiotherapy alone with a total dose of 50 Gy in conventional fractionation,and 55 patients received the same radiotherapy combined with chemotherapy consisting cisplatin 20 mg/m2 d1~d5,5-Fu 500 mg/m2 d1~d5,repeated after 28 days.Results The KPS scores were significant higher in patients treated by combined chemoradiotherapy.The 3-year ...
Keywords:Esophagdel cancer  Chemotherapy  Radio group  Survival rate  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号